Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats
- 1 February 2001
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 37 (2) , 604-608
- https://doi.org/10.1161/01.hyp.37.2.604
Abstract
Angiotensin II is an important modulator of cell growth through AT 1 receptors, as demonstrated both in vivo and in vitro. We investigated the role of proteins involved in the cell cycle, including cyclin D1, cyclin-dependent kinase 4 (cdk4), and cyclin-dependent kinase inhibitors p21 and p27 in blood vessels of angiotensin II–infused rats and the effect therein of the AT 1 -receptor antagonist losartan. Male Sprague-Dawley rats were infused for 7 days with angiotensin II (120 ng/kg per minute SC) and/or treated with losartan (10 mg/kg per day orally). DNA synthesis in mesenteric arteries was evaluated by radiolabeled 3 H-thymidine incorporation. The expression of cyclin D1, cdk4, p21, and p27, which play critical roles during the G 1 -phase of the cell cycle process, was examined by Western blot analysis. Tail-cuff systolic blood pressure (mm Hg) was elevated ( P 3 H-thymidine incorporation (cpm/100 μg DNA) showed that angiotensin II infusion significantly increased DNA synthesis (152±5% versus 102±6% of control rats, P 1 receptors are stimulated in vivo, DNA synthesis is enhanced in blood vessels by activation of cyclin D1 and cdk4. Reduction in cell cycle kinase inhibitors p21 and p27 may contribute to activation of growth induced by in vivo AT 1 receptor stimulation.Keywords
This publication has 23 references indexed in Scilit:
- Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic FactorsThe Journal of cell biology, 2000
- A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophyJournal of Clinical Investigation, 1999
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Mammalian G1 cyclinsCurrent Opinion in Cell Biology, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Small artery structure in hypertension. Dual processes of remodeling and growth.Hypertension, 1993
- Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4Genes & Development, 1993
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993
- Cerebral vascular changes during chronic hypertensionJournal Of Hypertension, 1992